Search
for
Sort by
Research 541–570 of 1000+
- Acne as a chronic systemic disease
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Steroidogenesis of the testis – new genes and pathways
- Activator Protein-1 Activity Regulates Epithelial Tumor Cell Identity
- Anti-androgenic activities of Ganoderma lucidum
- Combined Sabal and Urtica extract vs finasteride in BPH (Alken stage I–II)
- The clinical evaluation of hirsutism
- A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-<i>α</i>-Reductase in the Treatment of Androgenetic Alopecia
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α-reductase inhibitors GI198745 and finasteride
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
- Impaired Hair Follicle Morphogenesis and Cycling with Abnormal Epidermal Differentiation in nackt Mice, a Cathepsin L-Deficient Mutation
- Pre-receptor regulation of the androgen receptor
- Effects of the 5α-Reductase Inhibitor Finasteride on Serum Levels of Gonadal, Adrenal, and Hypophyseal Hormones and its Clinical Significance: A Prospective Clinical Study
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms.
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Intraoperative floppy-iris syndrome and finasteride intake
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Defects in Androgen Biosynthesis Causing 46,XY Disorders of Sexual Development
- Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5α-reductase II
- Acute urinary retention: risks and management.
- Clinical application of 5α-reductase inhibitors
- Diagnostic Criteria for Polycystic Ovarian Syndrome
- New 5?-reductase inhibitors: In vitro and in vivo effects
- 5α-Reductases In Human Physiology: an Unfolding Story
- Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb.